The present invention is directed to substituted indazole compounds of formula (I)
pharmaceutical compositions of these compounds and methods of use thereof. The compounds of the present invention are ketohexokinase (KHK) inhibitors, useful for treating or ameliorating a KHK mediated metabolic disorders and/or diseases such as obesity, Type II diabetes mellitus and Metabolic Syndrome X.
本发明涉及公式(I)的取代
吲唑化合物,这些化合物的药物组合物以及使用它们的方法。本发明的化合物是
酮基
己糖激酶(KHK)
抑制剂,可用于治疗或改善KHK介导的代谢紊乱和/或疾病,如肥胖症,2型糖尿病和代谢综合征X。